Welcome to our dedicated page for BlackRock Science and Technology Term Trust news (Ticker: BSTZ), a resource for investors and traders seeking the latest updates and insights on BlackRock Science and Technology Term Trust stock.
BlackRock Science and Technology Term Trust (BSTZ) is a non-diversified, closed-end management investment company managed by BlackRock, the world鈥檚 largest asset manager. BSTZ鈥檚 primary objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The trust鈥檚 portfolio is diverse, including Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, and Corporate Bonds.
BSTZ focuses on investing at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies, regardless of their market capitalization. This ensures that the trust capitalizes on the development, advancement, and use of science and technology to deliver value to its investors.
The trust鈥檚 strategic approach is designed to maximize returns by leveraging BlackRock's extensive experience and deep insights into market trends and technological advancements. Investors rely on BSTZ for a balanced mix of high-growth potential and income generation, making it a significant player in the financial landscape.
BlackRock's commitment to their clients is evident in their meticulous management of BSTZ, aimed at helping investors achieve a better financial future. Whether you are a large institution or an individual investor, BSTZ offers a robust platform for securing your financial goals through its diversified and strategically managed portfolio.
BlackRock announced final results for tender offers of three closed-end funds. The offers, which expired on November 19, 2024, were oversubscribed for each fund. Each fund will purchase shares from tendering shareholders on a pro rata basis. For BlackRock Science and Technology Term Trust (BSTZ), 19,714,994 shares were tendered, with 1,854,222 to be purchased at $22.3440 per share, representing a pro-ration factor of 0.09414755. Similar results were reported for BCX and BOE funds. Payments are expected within five business days after expiration.
BlackRock announced the expiration and preliminary results of tender offers for three closed-end funds: BSTZ, BCX, and BOE. Each fund offered to repurchase up to 2.5% of its outstanding common shares. The tender offers were significantly oversubscribed, with BCX receiving 20,587,371 shares tendered against 2,056,355 shares offered for repurchase. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of November 20, 2024.
BlackRock closed-end funds announced final results of their tender offers for up to 2.5% of outstanding common shares. The offers, which expired on August 20, 2024, were oversubscribed for each fund. As a result, shares will be purchased from all tendering shareholders on a pro rata basis. The BlackRock Science and Technology Term Trust (BSTZ) had 23,251,771 shares tendered, with 1,901,766 to be purchased at $21.4522 per share. The pro-ration factor for BSTZ is 0.08188543. Two other BlackRock funds, BCX and BOE, also reported their tender offer results. Payments for accepted shares are expected within five business days after the expiration date.
BlackRock closed-end funds BSTZ, BCX, and BOE announced the expiration and preliminary results of their tender offers for up to 2.5% of outstanding common shares. The offers, which began on July 19, 2024, and ended on August 20, 2024, were significantly oversubscribed. BSTZ offered 1,901,766 shares but received tenders for 23,251,771 shares. BCX and BOE also saw high demand, with tenders exceeding the offered amounts by over 10 times. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of August 21, 2024. Final results, including pro-ration factors, are expected to be announced around August 21, 2024.
BlackRock has released its first quarter commentary for Science and Technology Trust II (BSTZ). Since its IPO in June 2019, BSTZ has achieved a remarkable 95% return on market price, exceeding the S&P MidCap 400 Info Tech Index by 28%. In March 2021, BSTZ announced a 49% increase in its monthly distribution, now yielding an annualized rate of 5.4%. The fund currently holds 28 private investments, representing 25% of its portfolio, and indicates a strong pipeline for future investments.
FAQ
What is the current stock price of BlackRock Science and Technology Term Trust (BSTZ)?
What is the market cap of BlackRock Science and Technology Term Trust (BSTZ)?
What is the primary objective of BlackRock Science and Technology Term Trust (BSTZ)?
What types of securities are included in BSTZ鈥檚 portfolio?
How much of BSTZ鈥檚 assets are invested in science and technology companies?
What is the investment strategy of BSTZ?
Who manages BlackRock Science and Technology Term Trust (BSTZ)?
Why is BSTZ considered a non-diversified investment trust?
What kind of investors typically invest in BSTZ?
Does BSTZ invest in international companies?
How does BlackRock ensure the effective management of BSTZ?
What makes BSTZ a significant player in the financial market?
